NanJing Pharmaceutical Company Limited (600713.SS)
CNY 5.03
(0.8%)
CNY 5.03
(0.8%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 20.95 Billion CNY | -16.02% |
| 2022 | 24.95 Billion CNY | 20.84% |
| 2021 | 20.65 Billion CNY | 11.1% |
| 2020 | 18.58 Billion CNY | 6.56% |
| 2019 | 17.44 Billion CNY | 12.95% |
| 2018 | 15.44 Billion CNY | 21.25% |
| 2017 | 12.73 Billion CNY | 16.95% |
| 2016 | 10.89 Billion CNY | 9.93% |
| 2015 | 9.9 Billion CNY | 11.02% |
| 2014 | 8.92 Billion CNY | 6.74% |
| 2013 | 8.36 Billion CNY | 5.66% |
| 2012 | 7.91 Billion CNY | 3.22% |
| 2011 | 7.66 Billion CNY | 7.83% |
| 2010 | 7.11 Billion CNY | 23.16% |
| 2009 | 5.77 Billion CNY | 30.22% |
| 2008 | 4.43 Billion CNY | 3.14% |
| 2007 | 4.29 Billion CNY | 41.24% |
| 2006 | 3.04 Billion CNY | 13.48% |
| 2005 | 2.68 Billion CNY | 6.42% |
| 2004 | 2.51 Billion CNY | 24.87% |
| 2003 | 2.01 Billion CNY | 53.94% |
| 2002 | 1.31 Billion CNY | 87.84% |
| 2001 | 697.92 Million CNY | -5.98% |
| 2000 | 742.3 Million CNY | 48.0% |
| 1999 | 501.56 Million CNY | 13.91% |
| 1998 | 440.31 Million CNY | 109.87% |
| 1997 | 209.79 Million CNY | -5.61% |
| 1996 | 222.27 Million CNY | 16.92% |
| 1995 | 190.1 Million CNY | 7.72% |
| 1994 | 176.47 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 25.1 Billion CNY | 19.8% |
| 2024 Q2 | 24.26 Billion CNY | -3.34% |
| 2024 Q3 | 24.9 Billion CNY | 2.64% |
| 2023 Q1 | 25.95 Billion CNY | 4.0% |
| 2023 Q4 | 20.95 Billion CNY | -19.81% |
| 2023 Q3 | 26.13 Billion CNY | -1.11% |
| 2023 Q2 | 26.42 Billion CNY | 1.83% |
| 2023 FY | 20.95 Billion CNY | -16.02% |
| 2022 Q3 | 24.58 Billion CNY | 15.24% |
| 2022 Q1 | 21.73 Billion CNY | 5.23% |
| 2022 FY | 24.95 Billion CNY | 20.84% |
| 2022 Q4 | 24.95 Billion CNY | 1.52% |
| 2022 Q2 | 21.33 Billion CNY | -1.83% |
| 2021 Q2 | 20.49 Billion CNY | -1.29% |
| 2021 Q1 | 20.76 Billion CNY | 11.71% |
| 2021 FY | 20.65 Billion CNY | 11.1% |
| 2021 Q4 | 20.65 Billion CNY | -5.32% |
| 2021 Q3 | 21.81 Billion CNY | 6.42% |
| 2020 FY | 18.58 Billion CNY | 6.56% |
| 2020 Q1 | 19.63 Billion CNY | 12.56% |
| 2020 Q2 | 16.83 Billion CNY | -14.24% |
| 2020 Q3 | 18.12 Billion CNY | 7.62% |
| 2020 Q4 | 18.58 Billion CNY | 2.58% |
| 2019 Q2 | 17.79 Billion CNY | -0.6% |
| 2019 Q4 | 17.44 Billion CNY | -10.26% |
| 2019 Q3 | 19.44 Billion CNY | 9.27% |
| 2019 Q1 | 17.89 Billion CNY | 15.89% |
| 2019 FY | 17.44 Billion CNY | 12.95% |
| 2018 Q3 | 15.13 Billion CNY | 9.49% |
| 2018 FY | 15.44 Billion CNY | 21.25% |
| 2018 Q4 | 15.44 Billion CNY | 2.03% |
| 2018 Q2 | 13.82 Billion CNY | -0.38% |
| 2018 Q1 | 13.87 Billion CNY | 8.95% |
| 2017 Q4 | 12.73 Billion CNY | -3.94% |
| 2017 FY | 12.73 Billion CNY | 16.95% |
| 2017 Q3 | 13.26 Billion CNY | 14.6% |
| 2017 Q2 | 11.57 Billion CNY | -2.66% |
| 2017 Q1 | 11.88 Billion CNY | 9.14% |
| 2016 Q1 | 10.96 Billion CNY | 10.63% |
| 2016 Q3 | 12.1 Billion CNY | 13.07% |
| 2016 FY | 10.89 Billion CNY | 9.93% |
| 2016 Q2 | 10.7 Billion CNY | -2.35% |
| 2016 Q4 | 10.89 Billion CNY | -10.0% |
| 2015 Q2 | 9.95 Billion CNY | 4.72% |
| 2015 Q1 | 9.5 Billion CNY | 6.51% |
| 2015 Q3 | 10.6 Billion CNY | 6.5% |
| 2015 Q4 | 9.9 Billion CNY | -6.54% |
| 2015 FY | 9.9 Billion CNY | 11.02% |
| 2014 FY | 8.92 Billion CNY | 6.74% |
| 2014 Q1 | 9.19 Billion CNY | 9.96% |
| 2014 Q2 | 8.99 Billion CNY | -2.14% |
| 2014 Q3 | 9.96 Billion CNY | 10.75% |
| 2014 Q4 | 8.92 Billion CNY | -10.44% |
| 2013 Q1 | 8.21 Billion CNY | 3.82% |
| 2013 Q2 | 8.12 Billion CNY | -1.07% |
| 2013 Q3 | 8.97 Billion CNY | 10.46% |
| 2013 Q4 | 8.36 Billion CNY | -6.86% |
| 2013 FY | 8.36 Billion CNY | 5.66% |
| 2012 Q2 | 9.02 Billion CNY | 6.59% |
| 2012 Q3 | 9.17 Billion CNY | 1.59% |
| 2012 Q4 | 7.91 Billion CNY | -13.73% |
| 2012 FY | 7.91 Billion CNY | 3.22% |
| 2012 Q1 | 8.47 Billion CNY | 10.5% |
| 2011 Q2 | 8.09 Billion CNY | 0.08% |
| 2011 Q4 | 7.66 Billion CNY | -3.99% |
| 2011 Q3 | 7.98 Billion CNY | -1.36% |
| 2011 Q1 | 8.08 Billion CNY | 13.77% |
| 2011 FY | 7.66 Billion CNY | 7.83% |
| 2010 FY | 7.11 Billion CNY | 23.16% |
| 2010 Q4 | 7.11 Billion CNY | 10.62% |
| 2010 Q1 | 6.21 Billion CNY | 7.64% |
| 2010 Q3 | 6.42 Billion CNY | 2.55% |
| 2010 Q2 | 6.26 Billion CNY | 0.86% |
| 2009 Q2 | 5.68 Billion CNY | 14.39% |
| 2009 FY | 5.77 Billion CNY | 30.22% |
| 2009 Q4 | 5.77 Billion CNY | 5.78% |
| 2009 Q1 | 4.96 Billion CNY | 12.1% |
| 2009 Q3 | 5.45 Billion CNY | -4.01% |
| 2008 Q1 | 4.45 Billion CNY | 3.74% |
| 2008 Q2 | 4.63 Billion CNY | 3.92% |
| 2008 FY | 4.43 Billion CNY | 3.14% |
| 2008 Q3 | 4.77 Billion CNY | 3.05% |
| 2008 Q4 | 4.43 Billion CNY | -7.17% |
| 2007 Q4 | 4.29 Billion CNY | 1.71% |
| 2007 Q3 | 4.22 Billion CNY | 3.08% |
| 2007 Q2 | 4.1 Billion CNY | 22.66% |
| 2007 Q1 | 3.34 Billion CNY | 9.84% |
| 2007 FY | 4.29 Billion CNY | 41.24% |
| 2006 FY | 3.04 Billion CNY | 13.48% |
| 2006 Q1 | 2.89 Billion CNY | 7.97% |
| 2006 Q2 | 2.9 Billion CNY | 0.33% |
| 2006 Q3 | 2.97 Billion CNY | 2.43% |
| 2006 Q4 | 3.04 Billion CNY | 2.27% |
| 2005 FY | 2.68 Billion CNY | 6.42% |
| 2005 Q4 | 2.68 Billion CNY | -2.9% |
| 2005 Q3 | 2.76 Billion CNY | 4.12% |
| 2005 Q2 | 2.65 Billion CNY | 1.63% |
| 2005 Q1 | 2.61 Billion CNY | 3.58% |
| 2004 Q1 | 1.98 Billion CNY | -1.72% |
| 2004 Q2 | 2.2 Billion CNY | 11.27% |
| 2004 Q3 | 2.3 Billion CNY | 4.49% |
| 2004 FY | 2.51 Billion CNY | 24.87% |
| 2004 Q4 | 2.51 Billion CNY | 9.28% |
| 2003 Q2 | 1.81 Billion CNY | 31.3% |
| 2003 FY | 2.01 Billion CNY | 53.94% |
| 2003 Q4 | 2.01 Billion CNY | 7.28% |
| 2003 Q3 | 1.88 Billion CNY | 3.42% |
| 2003 Q1 | 1.38 Billion CNY | 5.67% |
| 2002 FY | 1.31 Billion CNY | 87.84% |
| 2002 Q1 | 840.63 Million CNY | 20.45% |
| 2002 Q2 | 876.95 Million CNY | 4.32% |
| 2002 Q3 | 939.45 Million CNY | 7.13% |
| 2002 Q4 | 1.31 Billion CNY | 39.55% |
| 2001 Q4 | 697.92 Million CNY | 0.0% |
| 2001 Q2 | 750.93 Million CNY | 0.0% |
| 2001 FY | 697.92 Million CNY | -5.98% |
| 2000 Q4 | 742.3 Million CNY | 0.0% |
| 2000 FY | 742.3 Million CNY | 48.0% |
| 2000 Q2 | 723.38 Million CNY | 0.0% |
| 1999 Q2 | 461.45 Million CNY | 0.0% |
| 1999 Q4 | 501.56 Million CNY | 0.0% |
| 1999 FY | 501.56 Million CNY | 13.91% |
| 1998 Q2 | 328.33 Million CNY | 0.0% |
| 1998 FY | 440.31 Million CNY | 109.87% |
| 1998 Q4 | 440.31 Million CNY | 0.0% |
| 1997 FY | 209.79 Million CNY | -5.61% |
| 1997 Q4 | 209.79 Million CNY | 0.0% |
| 1997 Q2 | 236.67 Million CNY | 0.0% |
| 1996 Q2 | 214.12 Million CNY | 0.0% |
| 1996 Q4 | 222.27 Million CNY | 0.0% |
| 1996 FY | 222.27 Million CNY | 16.92% |
| 1995 Q4 | 190.1 Million CNY | 0.0% |
| 1995 FY | 190.1 Million CNY | 7.72% |
| 1994 FY | 176.47 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 2.75 Billion CNY | -661.708% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.14 Billion CNY | -566.967% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.88 Billion CNY | -438.954% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 887.5 Million CNY | -2261.414% |
| Aurora Optoelectronics Co.,Ltd. | 1.09 Billion CNY | -1805.589% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 290.34 Million CNY | -7118.354% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 1.12 Billion CNY | -1770.312% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 527.57 Million CNY | -3872.484% |